Skip to main content
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. — Investor Relations & Filings

Ticker · OKUR ISIN · US75974E1038 US Manufacturing
Open in API
Filings indexed 342 across all filing types
Latest filing 2023-08-10 Interim / Quarterly Rep…
Country US United States of America
Listing US OKUR

About OnKure Therapeutics, Inc.

https://onkuretherapeutics.com/

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines for cancer patients. The company is building a pipeline of potentially best-in-class, tumor-agnostic therapies that target biologically validated drivers of cancers, particularly those underserved by current treatments. Its research and development efforts are centered on novel and potentially less toxic kinase inhibitor drugs and epigenetic therapies.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2023
2023-08-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release reporting the company's financial results for the second quarter ended June 30, 2023. The document states that the press release is furnished as an exhibit and is not "filed" for certain regulatory purposes, indicating this document is primarily an announcement of financial results rather than the full financial report itself. The document length is 3840 characters, which is relatively short and consistent with an earnings release or announcement rather than a full quarterly report. The key phrase "press release reporting the Company’s financial results for the second quarter" aligns with the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Therefore, the document should be classified as an Earnings Release (ER).
2023-08-10 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-27 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-23 English
Regulatory Filings 2023
Regulatory Filings
2023-06-23 English
Regulatory Filings 2023
Regulatory Filings
2023-06-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.